Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Republic HealthcareHKSE:08357 30 Current Ratio is 3.12 as of Jun. 2026, which is 44% below its 10-year median of 5.59. GuruFocus rates HKSE:08357 with a GF Score™ of 30/100 and a GF Value™ of HK$0.09 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Republic Healthcare ranks better than 79.97% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Republic Healthcare's current ratio for the quarter that ended in Jun. 2026 was 3.12.
Republic Healthcare has a current ratio of 3.12. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Republic Healthcare's Current Ratio or its related term are showing as below:
HKSE:08357'
s Current Ratio Range Over the Past 10 Years
Min: 1.41 Med: 5.59 Max: 10.04
Current: 3.12
During the past 10 years, Republic Healthcare's highest Current Ratio was 10.04. The lowest was 1.41. And the median was 5.59.
HKSE:08357's Current Ratio is ranked better than 79.97% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.455
vs HKSE:08357: 3.12
Republic Healthcare (HKSE:08357) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Republic Healthcare Current Ratio Related Terms
Republic Healthcare Current Ratio Historical Data
* Premium members only.
The historical data trend for Republic Healthcare's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08357 vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Republic Healthcare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Republic Healthcare Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Republic Healthcare's Current Ratio distribution charts can be found below:
* The bar in red indicates where Republic Healthcare's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Republic Healthcare (HKSE:08357) has a Current Ratio of 3.12 as of Jun. 2026. This is 44% below median its historical median of 5.59. Over the past decade, Republic Healthcare's Current Ratio has ranged from 1.41 to 10.04. According to the industry distribution chart, Republic Healthcare ranks #137 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 20%.
Is Republic Healthcare's Current Ratio too high?
Republic Healthcare's current Current Ratio of 3.12 is 44% below median its 10-year median of 5.59. Over the past 10 years, this metric has ranged from a low of 1.41 to a high of 10.04. The Healthcare Providers & Services industry median Current Ratio is 1.46. Republic Healthcare's value of 3.12 is 114.4% above this industry median. Based on the distribution chart, Republic Healthcare ranks #137 out of 684 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Republic Healthcare has a GF Score™ of 30/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Republic Healthcare's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Republic Healthcare ranks #137 out of 684 companies for Current Ratio. This places Republic Healthcare in the top 20% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.46. Republic Healthcare's value of 3.12 is 114.4% above this benchmark. Historically, Republic Healthcare's own Current Ratio has ranged from 1.41 to 10.04 over the past decade. While the company's 10-year median is 5.59 vs. the industry median of 1.46, Republic Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.46, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Republic Healthcare's current Current Ratio of 3.12 is 114.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Republic Healthcare's current Current Ratio is 3.12, which is 44% below median its own 10-year median of 5.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Republic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Republic Healthcare (HKSE:08357) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.10 — trading 14.4% above its estimated fair value. The current Current Ratio is 3.12, which is 44% below median its 10-year median of 5.59 and 114.4% above the Healthcare Providers & Services industry median of 1.46. Republic Healthcare's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Republic Healthcare (HKSE:08357), the current Current Ratio is 3.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Republic Healthcare (HKSE:08357) Overvalued in 2026?
Based on GuruFocus' analysis, Republic Healthcare stock appears to be overvalued.
The current stock price of HK$0.10 is trading 14.4% above its estimated GF Value™ of HK$0.09.
GuruFocus considers Republic Healthcare to be Modestly Overvalued.
Key valuation signals for HKSE:08357:
Current Ratio: 3.12 (44% below median its 10-year median of 5.59)
GF Value™: HK$0.09 vs. price of HK$0.10 (14.4% above fair value)
Industry Position: 114.4% above the Healthcare Providers & Services median (#137 of 684)
No single metric tells the full story. See the HKSE:08357 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Republic Healthcare Ltd is principally engaged in the clinic business in Singapore and the provision of management advisory services. The company provides healthcare services operating a network of general practice clinics, treatment solutions for common medical conditions with a focus on sexual health and infectious diseases, and operation of a medical aesthetics clinic that focuses on providing treatment solutions for common skin conditions and basic medical aesthetics services. The company is segments are medical services and education services. The Group is engaged in the operation of medical clinics and the provision of management advisory services, pepper trading business, and healthcare-related education business. It generates maximum revenue from Singapore.
30GF Score
Get the complete analysis for HKSE:08357
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08357 has been successfully added to your 
